PATENT CLAIM ANALYSIS

Application Number: 15956052
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["435", "006100"]

Abstract:
The present invention describes an association between genetic polymorphisms in the ceramide kinase-like (CERKL) gene and a predisposition to prolongation of the QT interval, and provides related methods for the prediction of such a predisposition, the administration of QT interval-prolonging compounds to individuals having such a predisposition, and determining whether a compound is capable of inducing QT prolongation.

Claim (Index 4):
The method of  claim 1 , wherein the second quantity is less than 24 mg/day.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 1.45455
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12593419', '14632914', '13263074', '15705054', '15705071']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6780714805856671
- 35 USC 102 Novelty (BERT): 0.600412909957692
- Combined Prediction Score: 0.6703056235228696
- Mean Citation Score: 491.280534
- Max Citation Score: 562.39215
- Similarity Product: 442.84384076057376

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test